Want to join the conversation?
Maker of connectivity and sensor solutions $TEL posted lower 2Q16 net income of $380MM or $1.03 per diluted share vs. $599MM or $1.45 per diluted share in 2Q15, hurt by lower income tax benefit. Adjusted EPS was $0.90 during 2Q16. Total net sales fell 4.22% to $2.95Bil vs. $3.08Bil in 2Q15, hurt by lower sales results in the three segments.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.